- Home
- ERAS vs AMAL Comparison
ERAS vs AMAL Comparison
Compare ERAS & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ERAS | AMAL |
|---|---|---|
| Founded | 2018 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ERAS | AMAL |
|---|---|---|
| Price | $9.53 | $33.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $5.33 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 7.9M | 196.4K |
| Earning Date | 11-12-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.32 |
| Revenue | N/A | ★ $305,836,000.00 |
| Revenue This Year | N/A | $10.09 |
| Revenue Next Year | N/A | $8.37 |
| P/E Ratio | ★ N/A | $10.44 |
| Revenue Growth | N/A | ★ 0.56 |
| 52 Week Low | $1.01 | $25.03 |
| 52 Week High | $9.87 | $37.26 |
Technical Indicators
Market Signals| Indicator | ERAS | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 88.98 | 56.92 |
| Support Level | $3.36 | $33.02 |
| Resistance Level | $6.49 | $35.04 |
| Average True Range (ATR) | 1.01 | 0.90 |
| MACD | 0.57 | -0.04 |
| Stochastic Oscillator | 92.85 | 62.95 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.